GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » CQ Pharmaceutical Holding Co Ltd (SZSE:000950) » Definitions » Capex-to-Operating-Income

CQ Pharmaceutical Holding Co (SZSE:000950) Capex-to-Operating-Income : 0.10 (As of Mar. 2024)


View and export this data going back to 1999. Start your Free Trial

What is CQ Pharmaceutical Holding Co Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

CQ Pharmaceutical Holding Co's Capital Expenditure for the three months ended in Mar. 2024 was ¥-47.92 Mil. Its Operating Income for the three months ended in Mar. 2024 was ¥506.24 Mil.

Hence, CQ Pharmaceutical Holding Co's Capex-to-Operating-Income for the three months ended in Mar. 2024 was 0.10.


CQ Pharmaceutical Holding Co Capex-to-Operating-Income Historical Data

The historical data trend for CQ Pharmaceutical Holding Co's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CQ Pharmaceutical Holding Co Capex-to-Operating-Income Chart

CQ Pharmaceutical Holding Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Operating-Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.59 0.20 0.20 0.11 0.10

CQ Pharmaceutical Holding Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capex-to-Operating-Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.07 0.05 0.08 0.23 0.10

Competitive Comparison of CQ Pharmaceutical Holding Co's Capex-to-Operating-Income

For the Medical Distribution subindustry, CQ Pharmaceutical Holding Co's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CQ Pharmaceutical Holding Co's Capex-to-Operating-Income Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, CQ Pharmaceutical Holding Co's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where CQ Pharmaceutical Holding Co's Capex-to-Operating-Income falls into.



CQ Pharmaceutical Holding Co Capex-to-Operating-Income Calculation

CQ Pharmaceutical Holding Co's Capex-to-Operating-Income for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-244.407) / 2458.88
=0.10

CQ Pharmaceutical Holding Co's Capex-to-Operating-Income for the quarter that ended in Mar. 2024 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-47.921) / 506.24
=0.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CQ Pharmaceutical Holding Co  (SZSE:000950) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


CQ Pharmaceutical Holding Co Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of CQ Pharmaceutical Holding Co's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


CQ Pharmaceutical Holding Co (SZSE:000950) Business Description

Traded in Other Exchanges
N/A
Address
333 Jinshi Avenue, Yubei District, Chongqing, CHN, 400010
CQ Pharmaceutical Holding Co Ltd distributes pharmaceutical products. It is the fixed-point reserve unit for drug and medical equipment of the central and Chongqing industries. The pharmaceutical business sector covers hospitals, pharmaceuticals, healthcare products, hospital sales, commercial wholesale, retail chains, terminal distribution, warehousing logistics and supply chain value-added services. Geographically, the group operates through China.
Executives
Yuan Quan Director
Qiu Tian Directors, executives
Li Yu Xiang Independent director
Wu De Bin Executives
Liu Ya Ping Securities Affairs Representative
Du Ping Executives

CQ Pharmaceutical Holding Co (SZSE:000950) Headlines

No Headlines